Mylan Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Akron, Inc. petitioned for inter partes review (IPR) of various patents owned by Allergan, Inc., which the Board instituted. One week before the scheduled IPR...more
3/12/2019
/ Administrative Proceedings ,
Allergan Inc ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
IP Assignment Agreements ,
Motion to Dismiss ,
Mylan Pharmaceuticals ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Reversal ,
Sovereign Immunity ,
Teva Pharmaceuticals ,
Tribal Governments ,
USPTO
In 2018, the U.S. Court of Appeals for the Federal Circuit docketed close to 600 appeals from the U.S. Patent and Trademark Office (USPTO). That is the second highest number since starting to hear post-American Invents Act...more
2/28/2019
/ § 315(b) ,
Adverse Judgments ,
Appeals ,
Article III ,
Assignor Estoppel ,
Burden of Proof ,
Burden-Shifting ,
Claim Construction ,
Collateral Estoppel ,
Corporate Counsel ,
Doctrine of Prosecution Disclaimer ,
Estoppel ,
Final Written Decisions ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Non-Appealable Decisions ,
Non-Practicing Entities ,
Obviousness ,
Oil States Energy Services v Greene's Energy Group ,
Partial Institution ,
Patent Litigation ,
Patent Owner Preliminary Response ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Precedential Opinion ,
Printed Publications ,
Prior Art ,
Private Property ,
Public Rights Doctrine ,
Real Party in Interest ,
Right to a Jury ,
Right To Appeal ,
SAS Institute Inc. v Iancu ,
Section 101 ,
Section 102 ,
Section 103 ,
Seventh Amendment ,
Sovereign Immunity ,
Standing ,
Time-Barred Claims
In 2016, the US Court of Appeals for the Federal Circuit docketed more appeals from the US Patent and Trademark Office (PTO) than any other venue—a first in its over 30-year history. The post grant proceedings created by the...more
3/19/2018
/ § 315(b) ,
Administrative Procedure ,
Administrative Procedure Act ,
America Invents Act ,
Anticipation ,
Appeals ,
Broadest Reasonable Interpretation Standard ,
Burden of Persuasion ,
Burden of Proof ,
Claim Amendments ,
Claim Construction ,
Due Process ,
Ex Partes Reexamination ,
Expert Testimony ,
Final Written Decisions ,
Incorporation by Reference ,
Inter Partes Review (IPR) Proceeding ,
Judicial Review ,
Non-Appealable Decisions ,
Notice Requirements ,
Obviousness ,
Patent Invalidity ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Preponderance of the Evidence ,
Prior Art ,
Reaffirmation ,
Remand ,
Reversal ,
Substantial Evidence Standard ,
Vacated